Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119258642 | 11925864 | 2 | F | 19991017 | 20160826 | 20160119 | 20160829 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-10727006 | BRISTOL MYERS SQUIBB | 0.00 | DY | M | Y | 1.90000 | KG | 20160829 | CN | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119258642 | 11925864 | 1 | PS | VIDEX | DIDANOSINE | 1 | Transplacental | UNK | U | 20156 | TABLET | ||||||||
119258642 | 11925864 | 2 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | UNK | Y | 0 | |||||||||
119258642 | 11925864 | 3 | SS | RETROVIR | ZIDOVUDINE | 1 | Oral | UNK | U | 0 | |||||||||
119258642 | 11925864 | 4 | SS | VIRAMUNE | NEVIRAPINE | 1 | Transplacental | UNK | U | 0 | |||||||||
119258642 | 11925864 | 5 | SS | SAQUINAVIR | SAQUINAVIR | 1 | Transplacental | UNK | U | 0 | |||||||||
119258642 | 11925864 | 6 | SS | RITONAVIR. | RITONAVIR | 1 | Transplacental | UNK | U | 0 | |||||||||
119258642 | 11925864 | 7 | C | CLAMOXYL | AMOXICILLINCLAVULANIC ACID | 1 | Transplacental | UNK | U | 0 | |||||||||
119258642 | 11925864 | 8 | SS | VIRAMUNE | NEVIRAPINE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119258642 | 11925864 | 1 | Product used for unknown indication |
119258642 | 11925864 | 2 | Product used for unknown indication |
119258642 | 11925864 | 3 | Product used for unknown indication |
119258642 | 11925864 | 4 | Product used for unknown indication |
119258642 | 11925864 | 5 | Product used for unknown indication |
119258642 | 11925864 | 6 | Product used for unknown indication |
119258642 | 11925864 | 7 | Product used for unknown indication |
119258642 | 11925864 | 8 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119258642 | 11925864 | CA |
119258642 | 11925864 | HO |
119258642 | 11925864 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119258642 | 11925864 | Anaemia | |
119258642 | 11925864 | Foetal exposure during pregnancy | |
119258642 | 11925864 | Gastrooesophageal reflux disease | |
119258642 | 11925864 | Premature baby | |
119258642 | 11925864 | Sickle cell anaemia | |
119258642 | 11925864 | Transfusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
119258642 | 11925864 | 2 | 19991017 | 19991023 | 0 |